Abstract
Inorganic metals and minerals for which there is evidence of carcinogenicity are identified. The risk of cancer from contact with them in the work place, the general environment, and under conditions of clinical (medical) exposure is discussed. The evidence indicates that minerals and metals most often influence cancer development through their action as cocarcinogens.
The relationship between the physical form of mineral fibers, smoking and carcinogenic risk is emphasized.
Metals are categorized as established (As, Be, Cr, Ni), suspected (Cd, Pb) and possible carcinogens Table 6), based on the existing in vitro, animal experimental and human epidemiological data. Cancer risk and possible modes of action of elements in each class are discussed. Views on mechanisms that may be responsible for the carcinogenicity of metals are updated and analysed.
Some specific examples of cancer risks associated with the clinical use of potentially carcinogenic metals and from radioactive pharmaceuticals used in therapy and diagnosis are presented. Questions are raised as to the effectiveness of conventional dosimetry in accurately measuring risk from radiopharmaccuticals.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Breslow L, Hoaglin L, Rasmussen G, Abrams HK: Occupations and cigarette smoking as factors in lung cancer. Am J Pub Health 44: 171–181, 1954
Doll R: Mortality from lung cancer in asbestos workers. Brit J Indust Med 12: 81–86, 1955
Craighead JE, Mossman BT: Pathogenesis of asbestos-associated discases. New Eng J Med 306: 1446–1455, 1982
McConnell EE, Wagner JC, Skidmore JW, Moore JA: Biological effects of man made fibers. IARC Meeting (Copenhagen, 1982) and WHO Regul. Office for Europe and IARC, 1983, pp 118–120
Wagner JC: Mineral fiber carcinogenesis. Am Chem Soc Monograph 182: 631–641, 1984
Mossman BT, Landesman JM, Eastman H, Bresnick E, Craighead JE: Interaction of asbestos and polycyclic aromatic hydrocarbons in carcinogenesis of the respiratory tract. In: Gee JB, Morgan WK, Brooks SM (eds) Occupational lung discase. Raven Press, New York, pp 171–172, 1984
Bignon J, Monchoux G, Chameaud J, Jaurand MC, Laufma J, Masse R: Incidence of various types of thoracic malignancy induced in rats by intrapleural injection of 2 mg of various mineral dusts after inhibition of 222 RA. Carcinogenesis 4: 621–628, 1983
Saracci R, Simonato L, Acheson ED, Andersen A, Bertazzi PA, Claude J, Charnay N, Esteve J, Frentzel-Beyme RR, Gardner MJ: Mortality and incidence of cancer of workers in the man made vitreous fibers producing indust.: An international investigation at 13 European plants. Brit J Ind Med 41: 425–436, 1984
Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A: Relation of particle dimension to carcinogenicity of amphibole asbestos and other fibrous minerals. J Natl Cancer Inst 67: 965–975, 1981
Chung H, Wiggs B: Lung asbestos content in chrysotile works with mesothelioma. Amer Rev Resp Dis 130: 1042–1045, 1984
Hughes JM, Weill H: Asbestos exposure-quantitative assessment of risk. Am Rev Respir Dis 133: 5–13, 1986
Selikoff IJ, Hammond EC: Asbestos and smoking. JAMA 242: 458–459, 1979
Hilt L, Langard S, Anderson A, Rosenberg J: Asbestos exposure, smoking habits and cancer incidence among production and maintenance workers in an electrochemical plant. Am J Ind Med 8: 1565–1577, 1985
Berry G, Newhouse ML, Antonis P: Combined effect of asbestos and smoking on mortality from lung cancer and mesothelioma in factory workers. Brit J Ind Med 42: 12–18, 1985
Newhouse ML, Berry G: Patterns of mortality in asbestos factory workers in London. Ann NY Acad Sci 330: 53–59, 1979
finkelstein MM: A study of dose-response relationships for asbestos associated disease. Brit J Ind Med 42: 319–325, 1985
Walker AM, Loughlin JE, Friedlander ER, Rothman KJ, Dreyer NA: Projections of asbestos-related disease 1980–2009. J Occup Med 25: 409–425, 1983
Heppleston AG: Pulmonary toxicology of silica coal and asbestos. Environ Health Persp 55: 111–127, 1984
Spurney KR: Natural fibrous zeolites and their carcinogenicity-a review. Sci Total Environ 30: 147–166, 1983
Rohl AN, Langer AM, Moncure G, Selikoff IJ, Fishbein A: Endemic pleural discase associated with mixed fibrous dusts in Turkey. Science 216: 518–520, 1982
Ozesmi M, Patiroglu TE, Hillerdal G, Ozesmi C: Peritoneal mesothelioma and malignant lymphoma in mice caused by fibrous zeolite. Brit J Ind Med 42: 746–749, 1985
Levine DS: Does asbestos exposure cause gastro intestinal cancer? Digest Dis Sci 30: 1189–1198, 1985
The 2nd. International workshop on in vitro effects of mineral ducts. Environ Health Perspect 51, 1983
Hei TK, Geard CR, Osmak RS, Travisano M: Correlation of in vitro genotoxicity and oncogenicity induced by radation and asbestos fibres. Br J Cancer 52: 591–597, 1985
Johnson NF, Davies R: Effect of asbestos on the P388D1 macrophagelike cell line: Preliminary ultrastructural observations. Environ Health Perspect 51: 109–117, 1983
Jaurand MC, Bastie-Sigeac I, Renier A, Bignon J: Comparative toxicities of different forms of asbestos on rat pleural mesothelial cells. Environ Health Perspect 51: 153–158, 1983
Bignon J, Jaurand MC: Biological in vitro and in vivo responses of chrysotile versus amphiboles. Environ Health Perspect 51: 73–80, 1983
Hesterberg TW, Barrett JC: Dependence of asbestos-and mineral dust-induced transformation of mammalian cells in culture on fiber dimension. Cancer Res 44: 2170–2180, 1984
Oshimura M, Hesterberg TW, Tsutsui T, Barrett JC: Correlation of asbestos-induced cytogenetic effects with cell transformation of syrian hamster embryo cells in culture. Cancer Res 44: 5017–5022, 1984
Desai R, Richards RJ: Effects of chrysotile on a lysosomal enzyme preparation and on the hydrolytic enzyme activity of cultured alvcolar macrophages. Environ Health Perspec 51: 125–130, 1983
Tilkes F, Beck EG: Macrophage functions after exposure to mineral fibers. Environ Health Perspect 51: 67–72, 1983
Hamilton JA: Suppression of the neutral protease activity of macrophages treated with asbestos in vitro. Environ Health Persp 51: 103–108, 1983
Donaldson K, Slight J, Hannant B, Bolton RE: Increased release of hydrogen peroxide & superoxide anion from asbestos-primed macrophages. Effect of hydrogen peroxide on the functional activity of alpha 1-protease inhibition. Inflammation 9: 139–147, 1985
Lechner JF: Tokiwa T, LaVeck M, Benedict WF, Banks-Schlegel S YeagerJr H, Banerjee A, Harris CC: Asbestos-associated chromosomal changes in human mesothelial cells. Proc Natl Acad Sci USA 82: 3884–3888, 1985
Woodworth CD, Mossman BT, Craighead JF: Induction of squamous metaplasia in organ cultures of hamster trachea by naturally occurring and synthetic fibers. Cancer Res 43: 4906–4912, 1983
Ginns LC, Ryu JH, Rogol PR, Sprince NI, Oliver LC, Larsson CJ: Natural killer cell activity in cigarette smokers and asbestos workers. Am Rev Respir Dis 131: 831–834, 1985
Oshimura M, Hesterberg TW, Barrett JC: An early, non-random karyotypic change in immortal syrian-hamster cell-lines transformed by asbestos — trisomy of chromosome-11. Can Gen Cytogen 22: 225–237, 1986
Price-Jones M, Gubbings G, Chamberlain M: The genetic effects of crocidolite asbestos: comparison of chromosome abnormalities and siter chromatid exchanges. Mutat Res 79: 331–336, 1980
Joseph LB, Stephens RE, Ottolenghi AC, Lipetz PD, Newman HAI: Morphological transformation in vitro of normal human fibroblasts by chrysotile. Environ Health Perspect 51: 17–22, 1983
Mossman BT, Jean L, Landesman JM: Studies using lectins to determine mineral interactions with cellular membranes. Environ Health Perspect 51: 23–25, 1983
Eastman A, Mossman BT, Bresnick E: Influence of asbestos on the uptake of benzo(a)pyrene and DNA alkylation in hamster tracheal epithelial cells. Cancer Res 43: 1251–1255, 1983
Bevan DR, Manger WE: Effect of particulates on metabolism and mutagenicity of benzo(a)pyrene. Chem Biol Interact 56: 13–28, 1985
Di Paolo JA, De Marinis AJ, Doniger J: Asbestos and benzo(a)pyrene synergism in the transformation of syrian hamster embryo cells. Pharmacol 27: 65–73, 1983
Mossman BT, Eastman A, Landesman JM, Bresnick E: Effects of crocidolite & chrysotile asbestos on cellular uptake and metabolism of benzo(a)pyrene in hamster tracheal epithelial cells. Environ Health Perspect 51: 331, 1983
Chamberlain M: Effect of mineral dusts on metabolic cooperation between chinese hamster V79 Cells in vitro. Environ Health Perspect 51: 5–9, 1983
Brown RC, Poole A, Fleming GTA: The influence of asbestos dust on the oncogenic transformation of C3H10T1/2 cells. Cancer Lett 18: 221–227, 1983
Chamberlain M, Tarmy EM: Asbestos and glass fibers in bacterial mutation tests. Mutat Res 43: 159–164, 1977
McDonald HD, Fay JS, Wooley JS, McDonald JC: Dust exposure and mortality in an American factory using chrysotile, amosite and crocidolite in mainly textile manufacture. Brit J Ind Med 40: 368–374, 1983
Workshop/Conference on the role of metals in carcinogenesis. Environ Health Perspect 40, 1981
Gilman JP, Swierenga SHH: Inorganic carcinogenesis. Am Chem Soc Monograph 182: 577–630, 1984
SundermanJr FW: Recent advances in metal carcinogenesis. Ann Clin Lab Sci 14: 93–122, 1984
IARC Working Group: An evaluation of chemicals and industrial processes associated with cancer in humans based on human and animal data. Cancer Res 40: 1–12, 1980
Nordberg GF, Andersen O: Metal interactions in carcinogenesis: Enhancement, inhibition. Environ Health Perspect 40: 65–81, 1981
Nordberg GF, Pershagen G: Metal interactions in carcinogenesis — effects of mixed exposures on carcinogenic response. Toxicol Environ Chem 9: 63–78, 1984
Rossman TG: Enhancement of UV-mutagenesis by low concentrations of arsenite in Escherichia coli. Mutat Res 91: 207–211, 1981
Lee TC, Oshimura M, Barrett JC: Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in syrian hamster embryo cell in culture. Carcinogenesis 6: 1421–1426, 1985
Chung HC, Liu CT: Induction of lung cancer in rats by intra-tracheal instillation of an arsenic containing ore dust. Zhonghua Zhonghui Zachi 4: 14–16, 1982
Ivankovics S, Esenbrand G, Preussman R: Lung carcinoma induction in BD rats after single intratracheal instillation of arsenic contain. pesticide mix. formerly used in vineyards. Int J Cancer 24: 786–788, 1979
Ishimishi N, Yamamoto A, Hisanaga A, Inamasu T: Tumorogenicity of arsenic trioxide to the lung in syrian golden hamsters by intermittent instillations. Cancer Lett 21: 141–147, 1983
Pershagen G, Bjorklund N-E: On the pulmonary tumorigenicity of arsenic trisulfide and calcium arsenate in hamsters. Cancer Lett 27: 99–104, 1985
Pershagen G, Nordberg G, Bjorklund N-E: Carcinoma of the respiratory tract in hamsters given arsenic trioxide and/or benzo(a)pyrene by the pulmonary route. Environ Res 34: 227–241, 1984
Pershagen G: The carcinogenicity of arsenic. Environ Health Perspect 40: 93–100, 1981
Pershagen G: Lung cancer mortality among men living near an arsenic emitting smelter. Amer J Epidemiol 122: 684–694, 1985
Lee-Feldstein A: Arsenic and respiratory cancer in humans, a follow up of copper smelter employecs in Montana. J Natl Cancer Inst 70: 601–610, 1983
Chen CJ, Chuang YC, Lin TM, Wu HY: Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: High-arsenic artesian well water and cancers. Cancer Res 45: 5895–5899, 1985
Grinspan D, Biagini R: Chronic endemic regional hydroarsenicism. The manifestations of arsenic poisoning caused by drinking water. Med Cutan Ibero Lat Am 13: 85–109, 1985
Wester PO, Brune D, Nordberg GF: Arsenic and selenium in lung, liver, and kidney tissuc from dead smelter workers. Br J Ind Med 38: 170–184, 1981
Brown CC, Chu KC: A new method for the analysis of cohort studies: Implications of the multistage theory of carcinogenesis appl. to occupational arsenic exposure. Environ Health Perspect 50: 293–308, 1983
Kuschner M: The carcinogenicity of beryllium. Environ Health Perspect 40: 101–105, 1981
Costa M, Kraker AJ, Patierno SR: Toxicity and carcinogenicity of essential and nonessential metals. Prog Clin Biochem Med 1, 1984
Vouk VB, Piver WI: Metallic elements on fossil fucl combustion products: Amounts and form of emissions and evaluation of carcinogenicity and mutagenicity. Environ Health Perspect 47: 201–225, 1983
Fishbein L: Environmental metallic carcinogens, an overview of exposures. J Toxicol Environ Health 2: 77–109, 1976
Rantanen J: Community and occupational studies of lung cancer and polycyclic organic matter. Environ Health Perspect 47: 325–332, 1983
Groth DH: Carcinogenicity of beryllium: Review of the literature. Environ Res 21: 56–62, 1980
Weiss W: Potential occupational causes of cancer I. The respiratory tract. NCI/ICRDB/OK-86/02
Progress in Nickel Toxicology. In: Brown SS, Sunderman Jr FW (eds) Blackwell Scientific Publications, Oxford, 1985
IARC Scientific Publication: Nickel in the human environment. IARC Sci P 53, 1984
SundermanJr FW: Recent progress in nickel carcinogenesis. Toxicol and Environ Chem 8: 235–252, 1984
Furst A, Radding SB: An update on nickel carcinogenesis. In: Nriagu JO (ed) Nickel in the environment. John Wiley & Sons, New York, 1980, pp 585–600
Norseth T: The carcinogenicity of chromium. Environ Health Perspect 40: 121–130, 1981
Hayes RB: Cancer and occupational exposure to chromium chemicals. In: Lillienfeld AM (ed) Reviews in cancer epidemiology v.l. Elsevier/N. Holland, 1980, pp 293–333
Langard S: The carcinogenicity of chromium compounds in man and animals. In: Burrows D (ed) Chromium metabolism and toxicity. CRC Press, Boca Raton, pp 13–30, 1983
Leonard A, Lauwerys RR: Carcinogenicity and mutagenicity of chromium. Mutat Res 76: 227–239, 1980
Egedahl R, Rice E: Cancer incidence at a hydrometalurgical refinery. IARC Sci Publ 53: 47–55, 1984
Redmond CK: Site specific cancer mortality among workers involved in the production of high nickel alloys. IARC Sci P 53: 73–86, 1984
Satoh K, Fukuda Y, Tork K, Katsuma N: Epidemiological study of workers engaged in the manufacture of chromium compounds. J Occup Med 23: 835–839, 1981
Alderson MR, Rattan NS, Bidstrup L: Health of workmen in the chromate producing industry in Britain. Brit J Ind Med 38: 117–124, 1981
Cornell RD, Landis JR: Mortality patterns among nickel/chromium alloy foundry workers. IARC Sci 53: 87–93, 1984
Polednak AP: Mortality among welders including a group exposed to nickel oxide. Arch Environ Health 36: 235–242, 1981
Langard S, Stern RM: Nickel in welding fumes—A cancer Hazard to welders? A review of epidemiological studies on cancer in welders. IARC Sci P 53: 95–103, 1984
Becker N, Claud J, Frentzel-Beyne RJ: Cancer risk of are welders exposed to fumes containing chromium and nickel. Scand J Work Environ Health, Apr 11 2: 175–182, 1985
Longstaff E, Walker ALT, Jackh R: Nickel oxide: Potential carcinogenicity — a review and further evidence. IARC Sci P 53: 235–243, 1984
SundermanJr FW: Carcinogenicity of nickel compounds in animals. IARC Sci P 53: 127–142, 1984
Piscator M: Role of cadmium in carcinogenesis with special reference to cancer of the prostate. Environ Health Perspect 40: 107–120, 1981
Lemen RA, Lee JS, Wagoner JK, Bleger HP: Cancer mortality among cadmium production workers. Ann NY Acad Sci 271: 273–279, 1976
Rivenson A, Silverman J: The prostate carcinoma in laboratory animals. A bibliography survey for 1900 to 1977. Invest Urol 16: 468, 1979
Hoffmann L, Putzke HP, Kamphl HJ, Russbuilt R, Gase P, Simona C, Erdmann T, Huckstorf C: Carcinogenic effects of cadmium on the prostate of the rat. J Cancer Res Chem Oncol 109: 193–199, 1985
Takenaka S, Oldiges H, Konig H: Carcinogenicity of calcium chloride acrosols in rats. J Natl Cancer Inst 70: 367–373, 1983
Sanders CL, Mahaffey JA: Carcinogenicity of single and multiple intratracheal instillations of cadmium oxide in the rat. Environ Res 33: 227–233, 1984
Armstrong BG; Kazantzis G: The mortality of cadmium workers. Lancet 1: 1424–1427, 1983
Cooper WC: Cancer and mortality patterns in the lead industry. Ann NY Acad Sci 272: 250–259, 1976
Rencher AC, Carter MW, McKee DW: A retrospective epidemiological study of mortality at a large western copper smelter. J Occup Med 19: 754–758, 1977
McMichael AJ, Johnson HM: Long-term mortality profile of heavily-exposed lead smelter workers. J Occup Med 24: 375–378, 1982
Shirai T, Ohshima M, Masuda A, Tomano S, Ito N: Promotion of 2(ethylnitrosamino)ethanol induced renal carcinogenesis in the rat by nephrotoxic compounds. Positive responses with folic acid. J Natl Cancer Inst 72: 477–480, 1984
Farber E: Chemical carcinogenesis. A biological perspective. Amer J Pathol 106: 271–296, 1982
Tanner DC, Lipsky MM: Effect of lead acetate on N-(4′-fluoro-4-biphenyl)acetamide-induced renal carcinogenesis in the rat. Carcinogenesis 5: 1109–1113, 1984
Kasprzak KS, Hooer KL, Poirier LA, Effect of dietary calcium acetate on lead subacetate carcinogenicity in the kidneys of male Sprague-Dawley rats. Carcinogenesis 6: 278–282, 1985
Koller LD, Kerkvliet NI, Exon JH: Neoplasia induced in male rats fed lead-acetate, ethyl urea, and sodium nitrite. Toxicol Path 13: 50–57, 1985
Kerkvliet NI, Baecher-Steppan L: Immunological studies on lead: Effects of exposure on tumor growth and cell mediated tumor immunity after synergistic or allogeneic stimulation. Immunopharmacology 4: 213–214, 1982
Poirier LA, Theiss JC, Arnold LJ, Sheinkin MB: Inhibition by magnesium and calcium acetates of lead subacetate and nickel acetate-induced tumors in strain Amice. Cancer Res 44: 1520–1522, 1984
Exon JH, Talcott PA, Koller LD: Effect of lead, polychlorinated biphenyls and cyclophosphamide on rat natural killer cells, interlcukin-2 and antibody synthesis. Fundamentals Appl Toxicol 5: 158–164, 1985
SundermanJr FW: Metal carcinogenesis. In: Goyer RA, Mehlman MA (eds) Advances in modern toxicology vol 1. Hemisphere Publ Co., Washington, 1977, pp 257–295
Gerhardsson L, Wester PO, Nordberg GF, Brune D: Chromium, cobalt and lanthanum in lung, liver and kidney tissue from deceased smelter workers. Sci Total Environ 37: 233–246, 1984
Enterline PE, Marsh GM: Cancer among workers exposed to arsenic and other substances in a copper smelter. Am J Epidemiol 116: 895–911, 1982
Villar TG: Vineyard sprayer's lung. Clinical aspects. Amer Rev Resp Dis 110: 545–555, 1974
Pierson IIP: Pharmacological perturbation of murine melanoma growth by copper chelates. Cancer Letters 2: 1221–1233, 1985
Kazantzis G: Role of cobalt, iron, lead, manganese, mercury, platinum, selenium, and titanium in carcinogenesis. Environ Health Perspect 40: 143–161, 1981
Stokinger HE: A review of the world literature finds iron oxides noncarcinogenic. Am Ind Hyg Assoc J 45: 127–133, 1984
Warshawsky D, Bingham E, Niemeier RW: The effect of a cocarcinogen, ferric oxide, on the metabolism of benzo(a)pyrene in the isolated perfused lung. J Toxicol Environ Health 14: 191–209, 1984
Edling C: Radon daughter exposure and lung cancer. Br J Ind Med 42: 721–722. 1985
Radford EP, St. Clair Renard KG: Lung cancer in Swedish iron workers exposed to low doses of radon daughters. New Eng J Med 318: 1485–1494, 1984
Pham QT, Gaertner M, Mur TM, Braun D, Gabiano M, Sadoni P: Incidence of lung cancer among iron miners. Europ J Resp Disease 64: 534–540, 1983
Davies JM: Lung cancer mortality among workers making lead chromate and zinc chromate pigments at three English factories. Br J Med 41: 158–169, 1984
Langard S, Vigander T: Occurrence of lung cancer in workers producing chromium pigments. Br J Ind Med 40: 71–74, 1983
Sheffet A, Thind I, Miller AM, Louria DB: Cancer mortality in a pigment plant utilizing lead and zinc chromates. Arch Environ Health 37: 44–52, 1982
Duncan JR, Dreosti IE: Zinc intake, neoplastic DNA synthesis and chemical carcinogenesis in rats and mice. J Natl Cancer Inst 55: 195–196, 1975
Rath FW, Enke H: Effect of orally administered zinc on the inducibility of experimental brain tumors in the rat. Arch Geschwulstforsch 54: 201–207, 1984
Rockette HE, Arena VC: Mortality studies of aluminum reduction plant workers: Potroom and carbon department. J Occup Med 25: 549–557, 1983
Andersen A, Dahlberg BE, Magnus K, Wannag A: Risk of Cancer in the Norwegian aluminium industry. Int J Cancer 29: 295–298, 1982
Theriault G, Tremblay C, Cordier S, Gingras S: Bladder cancer in the aluminium industry. Lancet 28: 947–950, 1984
Wei HJ, Luo XM, Yang SP: Effects of molybdenum and tungsten on mammary carcinogenesis in SD rats. J Natl Cancer Inst 74: 469–473, 1985
Luo XM, Wei IIJ, Yang SP: Inhibitory effects of molybdenum on esophageal and forestomach carcinogenesis in rats. J Natl Cancer Inst 71: 75–80, 1983
IARC Monographs on the evaluation of carcinogenic risk to man. 9: 250–256, 1975
National Cancer Institute: NCI Bioassay of selenium sulfide (gavage study). NCI-TR 194, National Institutes of Health, Bethesda MD, 1980
Schrauzer GN, White DA, Schneide CJ: Inhibition of genesis of mammary tumors in C3H mice-effects of selenium and selenium-antagonistic elements and their possible role in human breast. In: BoiceJr JD, FraumeniJr JF (eds) Radiation carcinogenesis: Epidemiology & biological significance. Raven Press, NY, 1984 pp 241–252
Pence BC, Buddingh F: Effect of dietary selenium deficiency on incidence and size of 1,2-dimethylhydrazine-induced colon tumors in rats. J Nutr 115: 1196–1202, 1985
Clement IP: Selenium inhibition of chemical carcinogenesis. Fed Proc 44: 2573–2578, 1985
Willett WC, MacMahon B: Diet and cancer — an overview. New Eng J Med 310: 697, 1984
Lee KP, Trochimowicz HJ, Reinhardt CF: Pulmonary response of rats exposed to titanium dioxide (TiO2) by inhalation for two years. Toxicol Appl Pharmacol 79: 179–192, 1985
Furst A: Trace elements related to specific chronic diseases: Cancer. Geol Soc Am Mem 123: 109, 1971
Stenback F, Rowland J: Role of particle size in the formation of respiratory tract tumors induced by benzo(a)pyrene. Europ J Cancer 14: 321–326, 1978
Raveh J, Stich H, Sutter F: Titanplasma-beschichtetes Hohlschrauben und Rekonstruktionsplatten-system (THRP) zur Uberbruckung von Kieferdefekten. Chirurg 56: 337–344, 1985
Stout MG, Rawson RW: Minerals, trace elements, and cancer. In: Newell GR, Ellison NM (eds) Progress in cancer research therapeutics, vol 17. Raven Press, New York, 1981, pp 243–272
Hansen K, Stern RM: A survey of metal-induced mutagenicity in vitro and in vivo. J Am College Toxicol 3: 381–429, 1984
Baker RSU: Evaluation of metals in in vitro assays, interpretations of data and possible mechanisms of action. Toxicol and Environ Chem 7: 191–212, 1984
Babich H, Devanas MA, Stotzky G: The mediation of mutagenicity and clastogenicity of heavy metals by physicochemical factors. Environ Res 37: 253–286, 1985
Siroever M: Effects of metals in in vitro bioassays. Environ Health Perspect 40: 163–172, 1981
Leonard A, Gerber GB, Jacquet P: Carcinogenicity, mutagenicity, and teratogenicity of nickel. Mutal Res 87: 1–15, 1981
Reith A, Brogger A: Carcinogenicity and mutagenicity of nickel and nickel compounds. IARC Sci P 53: 175–192, 1984
Bianchi V, Celoti L, Lanfranchi G, Majone M, Marin G, Montaldi A, Sponza G, Tamino G, Venier P, Zantedeschi A, Levis AG: Genetic effects of chromium compounds. Mutat Res 117: 279–300, 1983
Jacobsen-Kram D, Montalbano D: The Reproductive Effects Assessment Group's report on the mutagenicity of inorganic arsenic. Environ Mutagen 7: 787–804, 1985
Gerber GB, Leonard A, Jacquet P: Toxicity, mutagenicity, and teratogenicity of lead. Mutat Res 76: 115–141, 1980
Sukumar S, Notario V, Martin-Zanca D, Barbacid M: Induction of mammary carcinomas in rats by nitrosomethylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature 306: 658–661, 1983
Saxholm HJK: Effects of nickel compounds in cell culture. IARC Sci P 53: 165–174, 1984
Workgroup Report: In vitro models and methods for bioassay and studies of cellular mechanisms. Environ Health Perspect 40: 35–42, 1981
Schultz PN, Warren G, Kosso C, Rogers S: Mutagenicity of a series of hexacondinate cobalt III compounds. Mutat Res 102: 393–400, 1982
Arlauskas A, Baker RSU, Bonin AM, Tandon RK: Mutagenicity of metal ions in bacteria. Environ Res 36: 379–388, 1985
Mandel R, Ryser HJ: Mutagenicity of cadmium in Salmonella typhimurium and its synergism with two nitrosamines. Mutat Res 138: 9–16, 1984
Rossman TG, Molina M: The genetic toxicology of metal compounds: II Enhancement of UV light-induced mutagenesis in Escherichia coli WP2. Environ Mutagen 8: 263–271, 1986
Haugen A, Tveito G, Hansteen I-L: Nickel (II) ions induced transformation in fetal human kidney epithelial cells in vitro. (Abstract) Proc AACR 27: 136, 1986
Lechner JF, Tokiwa T, McClendon IA, Haugen A: Effects of nickel sulfate on growth and differentiation of normal human bronchial epithelial cells. Carcinogenesis 12: 1697–1703, 1984
Biedermann K, Landolph JR: Induction of anchorage independence in human diploid foreskin fibroblasts. (Abstract) Proc AACR 27: 137, 1986
Leopold WR, Miller EC, Miller JA: Carcinogenicity of antitumor cis-platinum (II) coordination complexes in the mouse and rat. Cancer Res 30: 913–918, 1979
Christie NT, Costa M: In vitro assessment of the toxicity of metal compounds. III. Effects of metals on DNA structure and function in intact cells. Biol Trace Element Res 5: 55–71, 1983
Rafetto G, Parodi S, Parodi C, deFerrari M, Troigno R, Brambilla G: Direct interaction with cellular targets as the mechanism for chromium carcinogenesis. Tumori 63: 503–512, 1977
Swierenga SHH, McLean JR: Further insights into mechanisms of nickel-induced DNA damage: Studies with rat liver cells. In: Brown SS, SundermanJr FW (eds) Progress in nickel toxicology. Blackwell Sci P, Oxford, 1985, pp 101–104
Hansen K, Stern RM: Toxicity and transformation potency of nickel compounds in BHK cells in vitro. IARC Sci P 53: 193–200, 1984
Taylor RT, Stewart S, Hanna M: Cocytotoxicity/commutagenicity of arsenic in a chinese hamster ovary triple auxotroph. Natl Tech Info Serv, Springfield VA, (DE85000758); 16p, 1984
Teel RW: A comparison of the effect of selenium on the mutagenicity and metabolism of benzo[a]pyrene in rat and hamster liver 59 activ. systems. Cancer lett 24: 281–289, 1984
Zelikoff JT, Atkins NMJr, Rossman TG: Mutagenicity of soluble metal salts using the V79/HGPRT mutation assay. Environ Mutagen (8) Suppl. 6: 95, 1986
Jones CA, Callaham MF, Huberman E: Sodium fluoride enhances morphological transformation of syrian hamster embryo cells pretreated with chemical carcinogens. (Abstract) Proc AACR 27: 133, 1986
Klein W, Kocsis F, Wottawa A: DNA-repair and environmental contaminants. SGAE Ber No 2613, 1976
Sen P, Costa M: Induction of chromosomal damage in chinese hamster ovary cells by soluble and particulate nickel compounds: Preferential fragmentation. Cancer Res 45: 2320–2325, 1985
Durnam DM, Palmiter RD: Induction of metallothionein-I mRNA in cultured cells by heavy metals and iodoacetate: Evidence for gratuitous inducers. Mol Cell Biol 4: 484–491, 1984
Rossman TG: Effect of metals on mutagenesis and DNA repair. Environ Health Perspect 40: 189–195, 1981
Llagostera M, Garrido S, Guerrero R, Barbe J: Induction of SOS genes of Escherichia coli by chromium compounds. Environ Mutagen 8: 571–577, 1986
Jung EG, Trachsel B, Immich H: Arsenic as an inhibitor of the enzymes concerned in cellular recovery (dark repair). Germ Med Mo 14: 614–616, 1969
Loch-Caruso R. Corcos IA, Trosko JE: Inhibition of metabolic cooperation by metals. (Abstract) Toxicologist 6: 267, 1986
Loch-Caruso R, Trosko JE: Inhited intercellular communication as a mechanistic link between teratogenesis and carcinogenesis. In: CRC critical reviews in toxicology. v. 16, n. 2, CRC Press, 1985. pp 157–183, 1985
Mohindru A, Fischer JM, Rabinovitz M: Endogenous copper is cytotoxic to a lymphoma in primary culture which requires thiols for growth. Experientia 8: 1064–1066, 1985
Martell AE: Chemistry of carcinogenic metals. Environ Health Perspect 40: 207–226, 1981
Workgroup Report: Chemistry and metabolism of metals relevant to their carcinogenicity. Environ Health Perspect 40: 27–34, 1981
Evans RM, Davies PJA, Costa M: Video time-lapse microscopy of phagocytosis and intracellular fate of crystalline nickel sulfide particles in cultured mammalian cells. Cancer Res 42: 2729–2735, 1982
Berry JP, Galle P, Poupon MF, Pot-Deprun J, Chouroulinkov I, Judde JG, Dewally D: Electron microprobe in vitro study of interaction of carcinogenic nickel compounds with tumor cells. IARC Sci P 53: 153–164, 1984
Kuehn K, Fraser CB, SundermanJr FW: Phagocytosis of particulate nickel compounds by rat peritoneal macrophages in vitro. Carcinogenesis 3: 321–326, 1982
SundermanJr FW, McCully KS, Hopfer SM: Association between erythrocytes and renal cancers in rats following intrarenal injection of nickel compounds. Carcinogenesis 5: 1511–1517, 1984
Berry JP, Poupon MF, Judde JC, Galle P: In vitro electron microprobe of carcinogenic nickel compound interaction with tumor cells. Ann Clin Lab Sci 15: 109–120, 1985
DeFlora S, Bianchi V, Levis AG: Distinctive mechanisms for interaction of hexavalent and trivalent chromium with DNA. Toxicol and Environ Chem 8: 287–294. 1984
Jennette KW: The role of metals in carcinogenesis: Biochemistry and metabolism. Environ Health Perspect 40: 233–252, 1981
Borenfreund E, Puerner JA: Cytotoxicity of metals, metal-metal and metal-chelator combinations assayed in vitro. Toxicol 39: 121–134, 1986
Ciccarelli RB, Wetterhahn KE: Molecular basis for the action of nickel. IARC Sci P 53: 201–213, 1984
Popenoe EA, Schmaeler MA: Interaction of human DNA polymerase B with ions of copper, lead, and cadmium. Arch Biochem Biophys 196: 109–120, 1979
Borochov N, Ausio J, Eisenberg H: Interaction and conformational changes of chromatin with divalent ions. Nuclei Acids Res 12: 3089–3096, 1984
Patierno SR, Costa M: DNA-protein crosslinks induced by nickel compounds in intact mammalian cells. Chem Biol Interact 55: 75–91, 1985
Bourtayre P, Pizzorni L, Liquier J, Tabouri J, Tailland E, Labarre JF: Z-form induction in DNA by carcinogenic nickel compounds-an optical spectroscopy study. IARC Sci P 53: 227–234, 1984
Liquier J, Bourtagra P, Pizzorni L, Bournies F, Labarre JF, Taillandier E: Spectroscopic studies of conformational transitions in double standard DNAs in presence of carcinog, nickel cmpds and an antitumoral drug (SOAZ) Anticancer Res 1–2: 41–44, 1984
Viegas-Peguignot E, Derbin C, Lemeunier F, Taillandier E: Identification of left-handed 2-DNA by indirect immunofluorescence methods in metaphase chromosomes of a mammal. Annales de Genetique 25: 218–222, 1982
Gallicchio VS: Inhibition of dimethyl sulfoxide-induced Friend crythroleukemia cell differentiation in vitro by lithium chloride. Exp Cell Biol 53: 287–293, 1985
Swierenga SHH: Unpublished data
Ono H, Wada O, Ono T: Distribution of trace metals in nuclei and nucleoli of normal & regenerating rat liver ... spec. ref ... diff. behavior of nickel and chromium. J Toxicol Environ Health 8: 947–957, 1981
Patierno SR, Sugiyama M, Basilion JP, Costa M: Preferential DNA-protein cross-linking by NiCl2 in magnesium-insoluble regions of fractionated chinese hamster ovary cell chromatin. Cancer Res 45: 5787–5794, 1985
Patierno SR, Costa M: Nickel ions preferentially affect a magnesium-insoluble fraction of sonicated chinese hamster overy (CHO) cell chromatin. (Abstract) Proc AACR 27: 101, 1986
Wedrychowski A, Schmidt WN, Ward WS, Hnilica LS: Cross-linking of cytokeratins to DNA in vivo by chromium salt and cis-diamminedichloroplatinum (II). Biochem 25: 1–9, 1986
Kovacs P, Darvas Z: Studies on the Ni content of the centriole. Acta Histochem 71: 169–173, 1982
Swierenga SHH, Basrur PK: Effect of nickel on cultured rat embryo muscle cells. Lab Invest 19: 633–674, 1968
Pearse AGE: In: Histochemistry. Theoretical and applied. 2nd ed. Little, Brown & Co., Boston, 1968
Katsuma Y, Swierenga SHH, Marccau N, French SW: Intermediate filaments as possible cytoskeletal links between nucleus and cell surface as seen in whole mount liver epithelial cells. Proc Am Ass Study Liver Diseases (in press).
Capco DG, Wan KM, Penman S: The nuclear matrix: Three dimensional architecture and protein composition. Cell 29: 847–858, 1982
Hsu TC: A possible function of constitutative heterochromatin: The bodyguard hypothesis. Genetics 79: 137–150, 1975
Capco DG, Penman S: Mitotic architecture of the cell: The filamentous networks of the nucleus and cytoplasm. J Cell Biol 96: 896–906, 1983
Goldman RA, Green K, Jones J, Lieska N, Yang H-Y: Intermediate filaments: Possible functions as cytoskeletal connecting links between the nucleus and the cell surface. Ann NY Acad Sci 455: 1–17, 1985
Blobel G: Gene gating: A hypothesis. Proc Natl Acad Sci USA 82: 8527–8529, 1985
Huber BE, Heilman SS, Thorgeirsson SS: Gene expression in the progressive development of hepatocellular carcinoma (HCC) in the rat. Proc AACR (abstract) 27: 7, 1986
Reiss M, Sartorelli AC: Transforming growth factor B induces differentiation of cultured human squamous cell carcinomas in presence of epidermal growth factor. Proc AACR (abstract) 27: 227, 1986
Swierenga SHH, McLean JR: Genotoxicity of stannous chloride in mammalian cell tests. In: Brown SS, Savory J (eds) Chemical toxicology and clinical chemistry of metals. Academic Press, London, 1983, pp 297–300
Robison SH, Cantoni O, Costa M: Strand breakage and decreased molecular weight of DNA induced by specific metal compounds. Carcinogenesis 3: 657–662, 1982
Swierenga SHH, McLean JR: Unpublished data
Rhim JS, Fujita J, Park JB: Activation of different cellular transforming genes, met and H-ras in chemically transformed human cell lines. Proc AACR (abstract) 27: 137, 1986
Saway MJ, Garte SJ: Activation of MYC and RAS oncogenes in radiation-induced rat skin tumors. Proc AACR, (abstract) 27: 6, 1986
Gibson D, Jaffe D, Barnhart K, Bowden GT: Detection of activated oncogenes in urethane and cisplatin induced mouse skin tumors. Proc AACR 27: 76, 1986
Squibb KS, Fowler BA: Relationship between metal toxicity to subcellular systems and the carcinogenic response. Environ Health Perspect 40: 181–188, 1981
Birnboim HC: Mechanism of superoxide anion-induced DNA strand breakage in tumor promoter-treated human neutrophils. (Abstract) Proc AACR 27: 146, 1986
Freeman B: Biology of disease: free radicals and tissue injury. Lab Invest 47: 412–426, 1982
Scott JA: A role of cytoskeletal integrity in cellular transformation. J Theor Biol 106: 183–188, 1984
Lewis JG, Adams DO: Correlation between inflammation in skin, release of H202 by macrophages & sensitivity to promotion of skin tumors by phorbol esters. (Abstract) Proc AACR 27: 146, 1986
Weitzman SA, Stossel TP: Phagocyte-induced mutation in chinese-hamster ovary cells. Cancer Lett 22: 337–341, 1984
Williams SJ, Karis MA, Menzel DB: Interactions of heavy metals with the pulmonary metabolism of [3H]benzo[a]pyrene. Environ Res 34: 212–226, 1984
Kandaswami C, Rahimtula M, O'Brien PJ: Effect of asbestos fibers on aryl hydrocarbon hydroxylase and aminopyrinc N-demethylase activities of rat liver microsomes. Toxicology 38: 119–132, 1986
Hei TK, Geard CR, Hall EJ: Effects of cellular nonprotein sulbydryl depletion in radiation-induced oncogenic transformation and genotoxicity in mouse C3H10T1/2 cells. Int J Rad O 10: 1255–1259, 1984
Sunderman Jr FW: Effects of NiCl2 and diethyldithiocarbamate on heme oxygenese, metallothionein, glutathione, and trace metal in rat liver and kidney, In: Brown SS, Sunderman Jr FW (eds) Progress in Nickel Toxicology, Blackwell Sci P, 1985, pp 157–160
Rosenberg B: Fundamental studies with cisplatin. Cancer 55: 2303–2316, 1985
Sleijfer DT, Meijer S, Mulder NH: Cisplatin: A review of clinical applications and renal toxicity. Pharm Weekbl [Sci] 7: 237–244, 1985
Eastman A: Comparison of the adducts formed in DNA in cis- and trans-Diamminedichloroplatinum (II). Proc AACR (abstract) 27: 291, 1986
Newman RA, Khokhar AR, Sunderland BA, Travis EL, Wassermann K, Bulger RE: Comparison of renal & intestinal tox. of cisplatin (DDP) and N-Methyl-Iminodiacetato-Diaminocyclohexane platinum II (MIDP) in rodents. Proc AACR (abstract) 27: 289, 1986
McPherson RA, Roh JK, Komanduri K, Mhatre R, Woolley PV, Rahman A: Toxicological evaluation of tetraplatin (NSC 363812) in comparison to CDDP. (Abstract No. 32) Proc AACR 27: 291, 1986
Mikhael NZ, Mueller RW, Stewart DJ, Kacew S: Morphometric and histopathologic analysis of glomerular changes in patients receiving cisplatin therapy. (Abstract) Proc Tox Path, 1985
Bark GA, Magin RL: Reduction of cis-diamminedichloroplatinum (CDDP) Toxicity by sodium thiosulfate or sodium selenite. Proc of AACR (abstract) 27: 289, 1986
Perez-Soler R, Khokbar AR, Lopez-Berestein G: Treatment/prophylaxis of exp. liver metastases with cis-bisneodecanoate-2, 3-diaminocyclohexane-platinum (II) encapsulated in liposome. Proc AACR (abstract) 27: 403, 1986
Smith JW, Neefe J, Orantes D, Mahoney K, Venditti J, Rahman A: Immunotoxicity of tetraplatinum in comparison with cis-platinum (CDDP) and carboplatinum (CBDCA) in mice. Proc AACR 27: 290, 1986
Fico ME, Poirier KA, Watrach AM, Watrach MA, Milner JA: Differential effects of selenium on normal and neoplastic canine mammary cells. Cancer Res 46: 3384–3388, 1986
Buell DN: Potential Hazards of selenium as a chemopreventive agent. Seminol Oncol 10: 311–321, 1983
Johnson RK, Faucette LF, McCabe FL, Rush GF, Goldstein RS, Mirabelli CK: Therapeutic and toxicologic properties of Bis[1,2-bis-(diphenyl-phosphino)ethane]gold (1) chloride (SK&F 101772). (Abstract) Proc AACR 27: 281, 1986
Mirabelli CK, Sung C-M, Jensen B, Mattern MR, Hill DT, Heyes RJ, Dean SW, Schein PS, Berners-Price S, Sadler PJ, Johnson RK, Crooke ST: Molecular Pharmacology of bis(diphenylphosphino)ethane-gold complexes: A novel class of antitumor agents. (Abstract) Proc AACR 27: 281, 1986
Kopf-Maier P, Moormann A, Kopf H: Activity of titanocene dihalides against a human colon carcinoma heterotransplanted to athymic mice. Fur J Cancer Clin Oncol 21: 853–857, 1985
Kopf-Maier P, Hesse A: Immunologic response to the treatment of Ehrlich ascites tumor with titanocene dichloride. J Cancer Res Clin Oncol 108: 254–255, 1984
Murray JB: Lithium therapy for mania and depression. J Gen Psychol 112: 5–33, 1985
Prakash R: Lithium-responsive schizophrenia: Case reports. J Clin Psychiatry 46: 141–142, 1985
Fawcett J, Clark DC, Gibbons RA, Aagesen CA, Pisani VD, Tilkin JM, Sellers D, Stutzman D: Evaluation of lithium therapy for alcoholism. J Clin Psychiatry 45: 494–499, 1984
Leber P: Lithium leukocytosis, and leukemia: The probable influence of biologic plausibility on clinical concern. Psychopharmacol Bull 17: 10–13, 1981
Tamura S, Fujikura M, Takahashi S, Maebo A, Nakano T, Yamada W, Fujii J, Nabeshima K, Hada T, Higashino K: The effect of lithium carbonate against leukopenia during systemic chemotherapy in patients with small cell carcinoma of the lung. Gan To Kagaku Ryoho 12: 2338–2344, 1985
HornsJr RC, Schrier SL, Greenberg PL: Lithium treatment in adults with acute myeloid leukemia receiving chemotherapy. Med Pediatr Oncol 12: 169–172, 1984
Stein RS, Volger WR, Lefante J: Failure of lithium to limit neutropenia significantly during induction therapy of acute myelogenous leukemia. Am J Clin Oncol 7: 365–369, 1984
Lyman GH, Williams CC, Dinwoodie WR, Schocken DD: Sudden death in cancer patients receiving lithium. J Clin Oncol 2: 1270–1276, 1984
Visca U, Guilivi A, Ventura M, Spina M, Massari A, Pomo A, Santi G: Effect of lithium carbonate on monocyte to macrophage maturation in cancer patients. Roll Ist Sieroter Milan 63: 154–159, 1984
Wahlin A, Knorringh L, Roos G: Altered distribution of T lymphocyte subsets in lithium-treated patients. Neuropsychobiology 11: 243–246, 1984
Waller DG, George CF: Lithium and the kidney. Adverse Drug React Acute Poisoning Rev 3: 65–89, 1984
Bear RA, Sugar L, Paul M: Nephrotic syndrome and renal failure secondary to lithium carbonate therapy. Can Med Assoc J 132: 735–737, 1985
West AP: Lithium-induced neurotoxicity and irreversible brain damage: A possible mechanism and antidote. J Clin Psychiatry 46: 300, 1985
Myers DH, Carter RA, Burns BH, Armond A, Hussain SB, Chengapa VK: A prospective study of the effects of lithium on thyroid function and on the prevalence of antithyroid antibodies. Psychol Med 15: 55–61, 1985
Montalescot G, Levy Y, Farge D, Brockhard L, Fantin B, Annouk C, Hatt PY: Lithium causing a serious sinus-node dysfunction at therapeutic doses. Clin Cardiol 7: 617–620, 1984
Sethi BB, Prakash R, Sethi N: Adverse drug relations-more on lithium-related leukemia. Psychopharmacol Bull 17: 5, 1981
Orr LE, McKerna JF: Lithium reinduction of acute myeloblastic leukemia. Lancet 24: 449–450, 1979
Pesce A, Gratecos N, Cassuto JP, Bare E, Dujardin E: Lithium and acute myelomonocytic leukemia. Presse Med 23: 1175, 1983
Witz F, Rigon JL, Lederlin P, Aymard JP, Rumilly F, Eisenmann JC, Herbeuval R: Lithium and acute myeloid leukemia. Sem Hop Paris 59: 559–560, 1983
Schou M. Lithium prophylaxis: Is the honeymoon over? Aust NZ J Psychiatry 13: 109–114, 1979
Resek G, Olivieri S: No association between lithium therapy and leukemia. Lancet 1: 940, 1983
Lyskowski J, Nasrallah HA: Lithium therapy and the risk for leukemia. Br J Psychiatry 139: 2561, 1981
Pochin E: Nuclear radiation: Risks and benefits. Oxford University Press 1983
Sorenson JA, Phelps ME: Physics in nuclear medicine. Grune and Stratton, New York, 1980, p 24
Loevinger R, Berman M: A revised schema for calculating the absorbed dose from biologically distributed radionuclides. Internal Radiation Dose Committee. Pamphlet no. 1, revised New York, Society of Nuclear Medicine, 1976
ICRP Publication 26: Recommendations of the International Commission on Radiological Protection. Annals of ICRP, vol 1, no 3, Pergamon Press, Oxford, 1977
UN Sci Committee on the Effects of Atomic Rad (UNSCEAR): Sources and effects of ionizing radiation. United Nations, New York, 1977
Goodhead DT: Models of radiation inactivation and mutagenesis. In: Meyn RE, Withers R (eds) Radiation biology in cancer research. Raven Press, New York, 1980, pp 231–247
Goodhead DT, Charlton DE: Analysis of high-let radiation effects in terms of local energy deposition. Rad Prot Dos 13: 253–258, 1985
Feinendegan LE, Booz J, Bond VP, Sondhaus AC: Microdosimetric approach to the analysis of cell responses at low dose and low dose rate. Rad Prot Dos 13: 299–306, 1985
Sastry KRS, Rao DV: Dosimetry of low energy electrons. In: Rao DV, Chandra R, Graham MC (eds) Physics of nulear medicine-recent advances. AAPM physics mono. 10, 1984, pp 169–208
Adelstein SJ, Kassis AI, Sastry KRS: Cellular versus organ approaches to dose estimates. Fourth International Radiopharmaceutical Dosimetry Symposium, Nov 5–8, 1985, Oakridge, Tenn. USA, pp. 13–24
Miyazaki N, Fujiwara Y: Mutagenic and lethal effects of [5–125I]iodo-2′-deoxyuridine incorporated into DNA of mammalian cells, and their RBE's. Radiat Res 88: 456–465, 1981
LeMotte PD, Adelstein SJ, Little JB: Malignant transformation induced by incorporated radionuclides in BALB/5T3mouse embryo fibroblasts. Proc Nat Acad Sci 79: 7763–7767, 1982
Kassis AI, Adelstein SJ, Haydock C, Sastry KSR, McElvany KD, Welch MJ: Lethality of Auger electrons from the decay of bromine-77 in the DNA of mamalian cells. Radiat Res 90: 362–373, 1982
Bloomer WD, McLaughlin WH, Weichselbaum RR, Tonneson GL, Hellmen S, Scitz D, Honson R, Adelstein S, Rosner A, Burstein N, Nove J, Little J: Iodine-125-labelled tamoxifen is differentially cytotoxic to cells containing oestrogen receptors. Int J Radiat Biol 38: 197–202, 1980
Commerford SL, Bond VP, Cronkete EP, Reincke V: Radiotoxicity of intranuclear I-125 atoms not bound to DNA. Int J Radiat Biol 37: 547–554, 1980
Krisch RE: Lethal effects of iodine-125 decay by electroncapture in Escherichia coli and bacteriophage T1. Int J Radiat Biol 21: 167–189, 1972
Hofer KG, Hughes WL: Radiotoxicity of intranuclear tritium, iodine-125 and iodine-131. Radiat Res 47: 94–109, 1971
Kassis AI, Adelstein SJ, Haydock C, Sastry KSR: Radiotoxicity of Sc-75 and S-35: Theory and application to a cellular model. Radiat Res 84: 407–425, 1980
Kassis AI, Sastry KSR, Adelstein SJ: Intracellular localization of Auger electron emitters: Biophysical dosimetry. Rad Prot Dos 13: 233–236, 1985
Hofer KG, Harris CR, Smith-Marshal J: Radiotoxicity of intranuclear Ga-67, I-125 and H-3. Nuclear versus cytoplasmic radiation effects in murine L1210 leukemia. Int J Radiat Biol 28: 225–241, 1975
Warters RI, Hofer KG, Harris CR, Smith JM: Radionuclides toxicity in cultured mammalian cells: Elucidation of the primary site of radiation damage. Curr Top Radiat Res O 12: 389–407, 1977
Ten-Berge RJM, Natarajan AT, Hordman MR: Labeling with erdium-III has detrimental effects on human lymphocytes. J Nucl Med 24: 615–620, 1983
Merz T, Tatum J, Hirsch J: Technetium-99 in labelled lymphocytes: A radiotoxicity study. J Nucl Med 27: 105–110, 1986
Rao DV, Govelitz GF, Sastry KSR: Radiotoxicity of thalium-201 in mouse testes: Inadequacy of conventional dosimetry. J Nucl Med 24: 145–153, 1983
Kassis AI, Adelstein SJ, Haydock C, Sastry KSR: Thalium 201: An experimental and a theoretical radioluological approach to dosimetry. J Nucl Med 24: 1164–1175, 1983
Rao DV, Sastry KSR, Gonelitz GF, Grimmond HE, Hill HZ: Radioluological effects of Auger electron emitter in vivo: Spermatogenesis in mice as an experimental model. Rad Prot Dos 13: 245–248, 1985
Rao DV, Govelitz G, Sastry KSR, Howell RW: Spermatogonial cell killing by radiolabelled methionine. A comparative study of the effect of Sc-75, S-35 and H-3. Fourth International Radiopharmaceutical Dosimetry Symposium. Nov 5–8, Oakbridge Tenn, 1985, pp 52–66
Goodhead DT, Thacker TJ, Cox R: Effectiveness of 0.3 keV carbon ultrasoft x-rays for the inactivation and mutation of cultured mammalian cells. Int J Radiat Biol 36: 101–114, 1979
Petkau A: Radiation carcinogenesis from a membrane perspective. Acta Physiol Scand Suppl 492: 81–90, 1980
Stazhevskaya NB, Struckov VA: Organization of supramolecular DNA complexes of the cukaryote chromatin and their role in the radiation effect. Radiobiologiya 17: 163–177, 1977
Konings AWT: Dose rate effects on lymphocyte survival. J Radiat Res 22: 282–285, 1981
Mukai FH, Goldstein BD: Mutagenicity of malond-aldehyde, a decomposition product of peroxidized polyunsaturated fatty acids. Science 191: 868–869, 1976
Yonei S, Furui H: Lethal and mutagenic effects of malond-aldehyde, a decomposition product of peroxidized lipids on E. coli with different DNA-repair capacities. Mutat Res 88: 23–32, 1981
Shamberger RJ, Adreone TL, Welles CE: Antioxidants and cancer IV. Initiating activity of malond-aldehyde as a carcinogen. J Nat Cancer Inst 53: 1771–1773, 1974
Yau TM: Mutagenicity and cytotoxicity of malond-aldehyde in mammalian cells. Meeh Ageing Dev 11: 137–144, 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Swierenga, S.H.H., Gilman, J.P.W. & McLean, J.R. Cancer risk from inorganics. Cancer Metast Rev 6, 113–154 (1987). https://doi.org/10.1007/BF00052846
Issue Date:
DOI: https://doi.org/10.1007/BF00052846